WO2005046624A1 - 化粧料組成物 - Google Patents
化粧料組成物 Download PDFInfo
- Publication number
- WO2005046624A1 WO2005046624A1 PCT/JP2004/016939 JP2004016939W WO2005046624A1 WO 2005046624 A1 WO2005046624 A1 WO 2005046624A1 JP 2004016939 W JP2004016939 W JP 2004016939W WO 2005046624 A1 WO2005046624 A1 WO 2005046624A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mol
- ion
- ions
- cosmetic composition
- concentration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to a cosmetic composition, particularly to a cosmetic composition effective for skin whitening and skin rejuvenation.
- antioxidants various substances such as ascorbic acid, ⁇ -tocopherol, polyphenols, and lignins have been studied. They exhibit strong antioxidant action like daltathione and are expected to have pharmacological action. There is life.
- antioxidants also act as oxidizing substances depending on conditions such as concentration and ⁇ , and in particular, ascorbic acid can act as an oxidizing substance at low concentrations such as 0.01M. (See, for example, Non-Patent Document 1).
- an aqueous solution containing salts and saccharides extends the shelf life of fresh food, and that the effect is an antioxidant effect (see, for example, Patent Document 1, Non-Patent Documents 2 and 3) .
- an aqueous solution can be used as a cosmetic useful for preventing dry skin and improving inflammation such as acne, and as a medicament effective for preventing and treating skin or mucous membrane diseases. (See, for example, Patent Documents 2 and 3).
- Patent Document 1 Japanese Patent Application Laid-Open No. 2001-346560
- Patent Document 2 Japanese Patent Application Laid-Open No. 2001-348321
- Patent Document 3 JP-A-2002-308783
- Non-Patent Document 1 FEBS Letters, 405, 186-190 (1997)
- Non-Patent Document 2 Proceedings of the 100th Annual Meeting of the Japanese Society of Animal Husbandry, 165 pages (2002)
- Non-Patent Document 3 2nd ABO Workshop Abstracts, 14 pages (2002)
- the inventors of the present invention act more safely and effectively on the human body and have only an antioxidant effect.
- an aqueous solution containing salts and saccharides, particularly glucose is suitable for that purpose, and The inventors have found that the composition is useful as a cosmetic composition effective for whitening and skin rejuvenation, and have completed the present invention.
- the present invention provides:
- a cosmetic composition comprising glucose at a concentration of 3 ZL and 0.01-0.03 mol ZL of sodium glutamate,
- composition according to the above (1) which is a whitening cosmetic
- composition according to (1) which is a skin rejuvenation cosmetic
- the present invention provides the composition according to the above (1), which is an aqueous solution.
- the skin whitening effect of the cosmetic composition of the present invention a power known to be due to the inhibitory effect of tyrosinase activity, such as arbutin, kojic acid and retinol, which triggers the production of melanin is known as the skin whitening effect of the cosmetic composition of the present invention.
- This is thought to be due to the decomposition of melanin granules produced inside the cells while increasing the vitality of the cells themselves, and the mechanism of the whitening effect is completely different from that of the past.
- the cosmetic composition of the present invention is an aqueous solution, particularly an aqueous solution, containing the above-mentioned salts including sodium glutamate as a solute and glucose.
- Salts may be selected from cosmetically acceptable compounds that supply Na ions, K ions, Ca ions and Mg ions as cations, and C1 ions and HCO ions as anions. They can be used in combination, and include seawater salts and raw salts. In particular, it has been found that the use of calcium lactate as a Ca ion source promotes the active uptake of Ca ions into cells, which is preferable.
- each ion has a molar ratio equivalent to that of normal extracellular fluids of mammals.
- the molar concentration ratio is 0.080-0.150 mol ZL: 0.02-0.04 mol ZL, typically, for example, the molar concentration ratio of each ion of Na: K: Ca: Mg is 0.14 mol ZL: 0.004 mol / L: 0.0025 mol ZL: 0.0015 mol ZL, the molar concentration ratio of each Cl: HCO ion
- the chloride ion in the molar concentration adjustment, for example, when 0.14 mol ZL of sodium chloride is added, the chloride ion also becomes 0.14 mol ZL, and this ratio cannot be obtained by a simple combination, but in the present invention, Then, it is supplemented with Na ions contained in sodium glutamate, whereby the whole solution is adjusted to have the above ratio.
- the content of sodium glutamate in the composition is selected in the range of 0.01 to 0.03 mol ZL.
- glucose in the composition is selected in the range of 0.05-0.15 mol ZL.
- saccharides for example, monosaccharides such as galactose, mannose, fructose, xylose and arabinose, disaccharides such as maltose, ratatose, sucrose and trehalose, and water-soluble oligosaccharides may be used in combination.
- monosaccharides such as galactose, mannose, fructose, xylose and arabinose
- disaccharides such as maltose, ratatose, sucrose and trehalose
- water-soluble oligosaccharides may be used in combination.
- mucoproteins such as collagen, gelatin, hyaluronic acid, chondroitin sulfate, mucoprotein, mucoprotein, etc. are added to the above solutes as long as the total molar concentration of the solutes does not exceed 0.54 mol / L. Sugar can be reduced. Furthermore, within this solute concentration range, Other active ingredients such as salamander extract, cinnamon extract, cinnamon extract, toki extract, shikimi extract, ginseng extract, licorice extract, and koninin extract, and other active ingredients such as inositol, niacin, niacinamide, glucuronic acid, and dalcosamine The material may be further added.
- active ingredients such as salamander extract, cinnamon extract, cinnamon extract, toki extract, shikimi extract, ginseng extract, licorice extract, and koninin extract, and other active ingredients such as inositol, niacin, niacinamide, glucuronic acid, and d
- the cosmetic composition of the present invention can be made into an aqueous solution, preferably an aqueous solution, by producing it by a method known per se such as mixing and dissolving desired components.
- a method known per se such as mixing and dissolving desired components.
- the pH can be adjusted to pH 7.35-7.45 suitable for the human body without any particular pH adjustment.
- the cosmetic of the present invention can be used, for example, for whitening skin, rejuvenating skin, etc. by applying it to the skin as appropriate.
- each component was dissolved in purified water to obtain a cosmetic composition of the present invention in the form of an aqueous solution.
- Example 1 HMGS-supplemented Mediuml54 was used, and with each component of Example 1 added at the concentration described in Example 1 (1.0-fold addition). After pre-fixing with daltaraldehyde, the cells were embedded and fixed, and the cells were observed with a JEOL JEM-2000EX electron microscope.
- FIG. 1 attached is a control plot
- FIG. 2 is an enlarged view of the cells in the test plot about 5300 times.
- Fig. 1 in the cells in the control group, a large number of melanin granules (black oval particles) were observed in the cells, and the separation of the cytoplasm packed with melanin granules was observed, but in the cells in the test group, As shown by the arrows, it was observed that the melanin granules were decomposed in the lysosome.
- Example 1 HMGS-added Mediuml54-treated group was used as a control, and each component of Example 1 was added at a concentration 0.5 times the concentration described in Example 1 (0.5-fold amount). ), The test group added at a 1.0-fold concentration (1.0-fold addition zone), and the test group added at a 1.5-fold concentration (1.5-fold addition kanaka group).
- NHEM cells were cultured for 8 days in a total of 4 sections. Samples were collected on the second, fourth and eighth days, respectively, and the melanin absorbance (475 nm) per protein amount was measured. Five specimens were collected from each plot, and the average standard deviation was used as the value for each plot.
- the cosmetic composition of the present invention exhibits a skin whitening effect by decomposing melanin granules.
- NHEM cells were cultured in the same manner as in Example 2 (2), and the effect of the additive on the cells was tested by MTT analysis, based on the rate of increase in formazan produced in mitochondria. Five samples were collected for each group, and the average standard deviation was used as the numerical value for each group.
- the cosmetic composition of the present invention also enhances cell activity.
- the cosmetic composition of the present invention exhibits excellent skin whitening effect and skin rejuvenation effect.
- FIG. 1 shows cells in a control section in Example 2.
- FIG. 2 shows cells in a test plot in Example 2.
- FIG. 3 is a graph showing the change over time in melanin measurement values in Example 2.
- FIG. 4 is a graph showing the change over time in the MTT analysis value in Example 3.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005515472A JPWO2005046624A1 (ja) | 2003-11-17 | 2004-11-15 | 化粧料組成物 |
EP04818536A EP1685823A4 (en) | 2003-11-17 | 2004-11-15 | COSMETIC COMPOSITION |
US10/575,473 US20070020207A1 (en) | 2003-11-17 | 2004-11-15 | Cosmetic composition |
US12/155,967 US20080292728A1 (en) | 2003-11-17 | 2008-06-12 | Cosmetic composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-386890 | 2003-11-17 | ||
JP2003386890 | 2003-11-17 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/155,967 Division US20080292728A1 (en) | 2003-11-17 | 2008-06-12 | Cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005046624A1 true WO2005046624A1 (ja) | 2005-05-26 |
Family
ID=34587409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/016939 WO2005046624A1 (ja) | 2003-11-17 | 2004-11-15 | 化粧料組成物 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20070020207A1 (ja) |
EP (1) | EP1685823A4 (ja) |
JP (1) | JPWO2005046624A1 (ja) |
KR (1) | KR20060116206A (ja) |
CN (1) | CN1882310A (ja) |
WO (1) | WO2005046624A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090263513A1 (en) * | 2008-04-18 | 2009-10-22 | Jan Marini | Cosmetic skin lightening formulation |
US20100247693A1 (en) * | 2009-03-24 | 2010-09-30 | Marini Jan L | Cosmetic formulation to treat rosacea telangiectasia |
KR20110001407A (ko) * | 2009-06-30 | 2011-01-06 | (주)아모레퍼시픽 | 지황, 감초, 의이인, 맥아, 모과, 오가피, 또는 갈근 추출물을 함유하는 지방 세포 분화 촉진 조성물 |
CN107496345A (zh) * | 2017-09-01 | 2017-12-22 | 安庆徽云博冠化妆品科技有限公司 | 一种蛋白螯合洗面奶及其制备方法 |
CN108324583B (zh) * | 2017-12-26 | 2019-10-18 | 浙江大学 | 一种在化妆品中激发金属活性离子的方法 |
CN108186381B (zh) * | 2017-12-26 | 2019-09-06 | 浙江大学 | 一种在化妆品中激发锌活性离子的方法 |
CN110141532A (zh) * | 2019-06-18 | 2019-08-20 | 东晟源研究院(广州)有限公司 | 分子筛靶向输送活性成分的护肤品配方及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03240730A (ja) * | 1990-02-15 | 1991-10-28 | Japan Fine Chem Kk | 細胞活性促進外用剤 |
JPH07126148A (ja) * | 1993-11-08 | 1995-05-16 | Sogo Yatsukou Kk | 化粧料 |
JP2002308783A (ja) * | 2001-04-13 | 2002-10-23 | Geo Co Ltd | 皮膚または粘膜疾患予防、治療用医薬組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3820840C1 (en) * | 1988-06-21 | 1989-11-09 | Friedhelm Dr. 6200 Wiesbaden De Beyersdorf | Aqueous reperfusion solution for reducing the reperfusion damage after acute peripheral vascular occlusion |
JPH07285844A (ja) * | 1994-04-13 | 1995-10-31 | Narisu Keshohin:Kk | 皮膚外用剤組成物 |
ES2153559T3 (es) * | 1995-01-09 | 2001-03-01 | Thorel Jean Noel | Medio nutritivo utilizable como medio de cultivo de celulas epidermicas y aplicaciones. |
-
2004
- 2004-11-15 US US10/575,473 patent/US20070020207A1/en not_active Abandoned
- 2004-11-15 EP EP04818536A patent/EP1685823A4/en not_active Withdrawn
- 2004-11-15 CN CNA2004800338436A patent/CN1882310A/zh active Pending
- 2004-11-15 JP JP2005515472A patent/JPWO2005046624A1/ja active Pending
- 2004-11-15 WO PCT/JP2004/016939 patent/WO2005046624A1/ja not_active Application Discontinuation
- 2004-11-15 KR KR1020067009401A patent/KR20060116206A/ko not_active Application Discontinuation
-
2008
- 2008-06-12 US US12/155,967 patent/US20080292728A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03240730A (ja) * | 1990-02-15 | 1991-10-28 | Japan Fine Chem Kk | 細胞活性促進外用剤 |
JPH07126148A (ja) * | 1993-11-08 | 1995-05-16 | Sogo Yatsukou Kk | 化粧料 |
JP2002308783A (ja) * | 2001-04-13 | 2002-10-23 | Geo Co Ltd | 皮膚または粘膜疾患予防、治療用医薬組成物 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1685823A4 * |
Also Published As
Publication number | Publication date |
---|---|
US20070020207A1 (en) | 2007-01-25 |
EP1685823A1 (en) | 2006-08-02 |
EP1685823A4 (en) | 2009-11-11 |
US20080292728A1 (en) | 2008-11-27 |
CN1882310A (zh) | 2006-12-20 |
KR20060116206A (ko) | 2006-11-14 |
JPWO2005046624A1 (ja) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11096960B2 (en) | Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same | |
KR101460969B1 (ko) | 피부 화장료 조성물 | |
US20080292728A1 (en) | Cosmetic composition | |
CN107496245B (zh) | 一种抗衰老脂质体组合物及其制备方法和应用 | |
CN106562891A (zh) | 一种多功能抗衰老敷面剂组合物 | |
KR100894628B1 (ko) | 인삼추출물 및 해양심층수를 포함하는 화장료 조성물 | |
CN107115448B (zh) | 一种具有美白抗衰老功效的中药组合物及其制备方法和用途 | |
CN113244152A (zh) | 一种白芨美肤修复护肤制剂及其制备方法和应用 | |
CN109771326B (zh) | 一种用于美白修护面膜的组合物 | |
EP2004235B1 (en) | Composition for cosmetic or pharmaceutical-dermatological use | |
JP2017200883A (ja) | 化粧料組成物、美白化粧料、細胞賦活化粧料、および、保湿化粧料 | |
CN113876682B (zh) | 一种珍珠粉自发泡洁面组合物及其制备方法和应用 | |
JPWO2007078009A1 (ja) | 化粧料 | |
KR102040245B1 (ko) | 알로에베라잎에 초정 광천수를 첨가하여 추출한 추출물을 함유하는 피부보습용 또는 피부노화방지용 화장료 조성물 | |
RU2704490C1 (ru) | Композиция против выпадения и стимулирующая рост волос | |
CN104053425A (zh) | 基于胶体银和脱氧核糖核酸的协同组合的医学护肤组合物 | |
KR100613422B1 (ko) | 피부 보습용 화장료 조성물 | |
JPS61246130A (ja) | 水性皮膚及び毛髪化粧料 | |
JPH1160481A (ja) | 皮膚外用剤のイオン導入液 | |
JP5751745B2 (ja) | セリシン由来のポリペプチドおよび角層剥離酵素保護剤 | |
JP7485499B2 (ja) | 塩基性水溶液を利用したピーリングジェルの製造方法 | |
CN111979289B (zh) | 植提物抵抗皮肤化学性刺激的细胞学评价方法及其应用 | |
JPH11180850A (ja) | 化粧料 | |
CN115887338A (zh) | 一种具有头皮抗衰功效的组合物及制备方法和应用 | |
KR100890235B1 (ko) | 증삼액 및 해양심층수를 포함하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480033843.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004818536 Country of ref document: EP Ref document number: 2007020207 Country of ref document: US Ref document number: 10575473 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005515472 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067009401 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2004818536 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067009401 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10575473 Country of ref document: US |